Michel Sadelain, M.D., Ph.D., joined Columbia University from Memorial Sloan Kettering, where he was the Stephen and Barbara Friedman Chair and director of the Center for Cell Engineering. Sadelain completed his M.D. at the University of Paris, conducted his Ph.D. research at the University of Alberta; and worked as a postdoctoral fellow at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology.
Dr. Sadelain has been elected to the American Society for Clinical Investigation, American Association for Cancer Research, American Society for Clinical Investigation, American Society of Gene and Cell Therapy, American Academy of Arts and Sciences, and the National Academy of Medicine of France.
Dr. Sadelain has won the Breakthrough Prize for Life Sciences, Canada Gairdner International Award, Warren Alpert Foundation Prize, American Society of Gene and Cell Therapy Outstanding Achievement Award, Leopold Griffuel Award, INSERM International Prize, Jacob and Louise Gabbay Award in Biotechnology and Medicine, Passano Laureate, Pasteur Weizmann/Servier Prize at the Academy of Sciences in Paris, Cancer Research Institute Coley Award, Merkin Prize, King Faisal Prize, Broermann Medical Innovation Award, and more.
